STERIS (NYSE:STE) Issues FY 2025 Earnings Guidance

STERIS (NYSE:STE) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 9.050-9.150 for the period, compared to the consensus EPS estimate of 9.060. The company issued revenue guidance of $5.4 billion-$5.4 billion, compared to the consensus revenue estimate of $5.5 billion.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on STE shares. Piper Sandler lifted their target price on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday. Stephens reiterated an “overweight” rating and set a $260.00 price objective on shares of STERIS in a research note on Thursday, November 7th. StockNews.com cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Finally, JMP Securities reissued a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research report on Monday, November 18th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $263.75.

STERIS Stock Performance

Shares of NYSE:STE traded up $1.57 on Wednesday, hitting $220.97. The company had a trading volume of 887,926 shares, compared to its average volume of 476,648. The stock has a market cap of $21.81 billion, a price-to-earnings ratio of 50.45 and a beta of 0.84. The stock has a 50 day moving average price of $212.26 and a 200 day moving average price of $224.61. STERIS has a 1-year low of $197.82 and a 1-year high of $248.24. The company has a current ratio of 2.41, a quick ratio of 1.55 and a debt-to-equity ratio of 0.33.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.02% and a return on equity of 13.78%. Analysts expect that STERIS will post 9.11 EPS for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio is 52.05%.

Insider Transactions at STERIS

In other STERIS news, SVP Cary L. Majors sold 1,682 shares of STERIS stock in a transaction on Monday, November 25th. The stock was sold at an average price of $217.32, for a total value of $365,532.24. Following the completion of the transaction, the senior vice president now directly owns 11,372 shares of the company’s stock, valued at $2,471,363.04. The trade was a 12.88 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.14% of the company’s stock.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.